Gerald Jäeger

Rituximab (anti‐CD20 monoclonal antibody) as consolidation of first‐line CHOP chemotherapy in patients with follicular lymphoma: a phase II study

R. Brezinschek, G. Höfler, P. Neumeister, 2002, European journal of haematology.